Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Neuro-Oncology Advances
|
November 29, 2023
Functional connectivity MRI provides an imaging correlate for chimeric antigen receptor T-cell-associated neurotoxicity
Sophia Stoecklein, Stephan Wunderlich, Boris Papazov, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2023
Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATE
Marcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 23, 2025
Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation
Nabeel Mansour, Julian Joram, Freba Grawe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 26, 2023
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATE
Marcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
EJNMMI Research
|
March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
Michael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
Blood Advances
|
September 25, 2023
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
Viktoria Blumenberg, Galina Busch, Stephan Baumann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
Conrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 19, 2026
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy
Conrad-Amadeus Voltin, Sarah Flossdorf, Lars Kurch, et al.
Blood Cancer Journal
|
August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma
Michael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Neuro-Oncology Advances
|
November 29, 2023
Functional connectivity MRI provides an imaging correlate for chimeric antigen receptor T-cell-associated neurotoxicity
Sophia Stoecklein, Stephan Wunderlich, Boris Papazov, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2023
Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATE
Marcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 23, 2025
Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation
Nabeel Mansour, Julian Joram, Freba Grawe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 26, 2023
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATE
Marcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
EJNMMI Research
|
March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
Michael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
Blood Advances
|
September 25, 2023
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
Viktoria Blumenberg, Galina Busch, Stephan Baumann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
Conrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 19, 2026
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy
Conrad-Amadeus Voltin, Sarah Flossdorf, Lars Kurch, et al.
Blood Cancer Journal
|
August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma
Michael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Page
of 5